Syneos Health, Inc.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40003657

Informations générales

Localisation

United States of America

Northern America

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

11/09/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Near-Term Targets: Syneos Health, Inc. commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by 2030 from a 2023 base year. Syneos Health, Inc. also commits to reduce absolute scope 3 GHG emissions from purchased goods and services and business travel 25.0% within the same timeframe.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

US87166B1026

LEI

549300IM8QZ2K8CD9246

Note

Expired commitment

Source : Science Based Targets initiative | Données publiques